t
Fevertree Drinks plc announced on April 14, 2026, the purchase of 128,130 of its ordinary shares of £0.0025 each through Investec Bank plc between April 7 and April 10, 2026. These purchases were made under the authority granted by shareholders at its 2025 Annual General Meeting on June 5, at prices ranging from 748.00p to 824.00p per share, and the Company intends to cancel the acquired shares.
| Date | 14 Apr 2026 |
| Time | 07:00:01 |
| Category | Capital structure |
| ID | 2465A |
14th April 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 7th April to 10th April 2026.
|
Date |
Venue |
Volume-weighted average price (p) |
Aggregated volume |
Lowest price per share (p) |
Highest price per share (p) |
|
07 April 2026 |
XLON |
769.0583 |
25,209 |
748.0000 |
779.0000 |
|
07 April 2026 |
AIMX |
776.0000 |
20,000 |
776.0000 |
776.0000 |
|
08 April 2026 |
XLON |
801.5459 |
1,701 |
779.5000 |
804.0000 |
|
09 April 2026 |
XLON |
805.0083 |
40,209 |
802.0000 |
814.5000 |
|
10 April 2026 |
XLON |
817.0306 |
41,011 |
806.0000 |
824.0000 |
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/2465A_1-2026-4-13.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024